Skip to site menu Skip to page content

Ypsomed Expands Offering for Clinical Studies

Ypsomed (SIX: YPSN) is expanding its clinical excellence offering to support faster and more reliable clinical trials for subcutaneous injectable drugs. With CliniPilot and the Clear-to-Clinic approach, Ypsomed combines ready-to-use...

[ajax_load_more container_type="div" css_classes="grid-x grid-padding-x" transition_container="false" post_type="pressreleases" images_loaded="true" posts_per_page="20" pause="true" offset="10" scroll="false" button_label="Load More Releases"]